FierceBiotech 2026-02-13 With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment
FierceBiotech 2026-02-13 After R&D head exits, Immunocore CEO pairs ambition with caution for growing cancer portfolio
FierceBiotech 2026-02-13 Integra LifeSciences cuts roles as 65 staffers impacted from Princeton, N.J., site
FierceBiotech 2026-02-13 Ultragenyx lays off 10% of workforce as FDA continues to stall gene therapy approval plans
FierceBiotech 2026-02-13 'When the markets opened, we were ready': Why biotech IPOs are back for 2026
FierceBiotech 2026-02-12 Icon shares plummet after CRO reveals accounting investigation, pulls 2025 guidance
FierceBiotech 2026-02-12 Lundbeck’s migraine prevention treatment sees ph. 2 success after trial’s earlier setback
FierceBiotech 2026-02-12 BridgeBio preps approval push after dwarfism drug increases children's height in phase 3
FierceBiotech 2026-02-12 Langer-backed biotech looks to end cancer recurrence with surgical revolution
FierceBiotech 2026-02-12 Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval
FierceBiotech 2026-02-12 Seres to lay off 30% of employees, pause lead program in latest strategic shift
FierceBiotech 2026-02-12 Sanofi ousts Paul Hudson after ‘bumpy ride’, poaches Merck KGaA CEO to lead the French pharma
FierceBiotech 2026-02-12 UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing
FierceBiotech 2026-02-11 ‘The only thing that saves us is data’: Allogeneic CAR-T biotechs fight for relevance as industry moves on